{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:13:59Z","timestamp":1779923639411,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10067-019-04625-y","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T21:02:23Z","timestamp":1559854943000},"page":"3677-3687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4796-4950","authenticated-orcid":false,"given":"Bogdan","family":"Obri\u0219c\u0103","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Jurubi\u021b\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Sorohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lin","family":"Baston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Bobeic\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Andronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Leca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gener","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"issue":"8","key":"4625_CR1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/ki.2009.247","volume":"76","author":"ED Charles","year":"2009","unstructured":"Charles ED, Dustin LB (2009) Hepatitis C virus-induced cryoglobulinemia. Kidney Int 76(8):818\u2013824. \nhttps:\/\/doi.org\/10.1038\/ki.2009.247","journal-title":"Kidney Int"},{"key":"4625_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jceh.2017.11.012","volume":"2017","author":"C Bunchorntavakul","year":"2018","unstructured":"Bunchorntavakul C, Mitrani R, Reddy KR (2018) Advances in HCV and cryoglobulinemic vasculitis in the era of DAAs: are we at the end of the road? J Clin Exp Hepatol 2017:1\u201314. \nhttps:\/\/doi.org\/10.1016\/j.jceh.2017.11.012","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"4625_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/j.ajkd.2006.09.015","volume":"49","author":"D Roccatello","year":"2007","unstructured":"Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, di Belgiojoso GB, Comotti C, Quarenghi MI (2007) Multicenter study on hepatitis C virus\u2013related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49(1):69\u201382. \nhttps:\/\/doi.org\/10.1053\/j.ajkd.2006.09.015","journal-title":"Am J Kidney Dis"},{"issue":"25","key":"4625_CR4","doi-asserted-by":"publisher","first-page":"41764","DOI":"10.18632\/oncotarget.16986","volume":"8","author":"D Roccatello","year":"2017","unstructured":"Roccatello D, Sciascia S, Rossi D, Solfietti L, Fenoglio R, Menegatti E, Baldovino S (2017) The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. Oncotarget. 8(25):41764\u201341777. \nhttps:\/\/doi.org\/10.18632\/oncotarget.16986","journal-title":"Oncotarget."},{"key":"4625_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.kint.2018.06.011","volume":"94","author":"M Jadoul","year":"2018","unstructured":"Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, Kamar N, Kasiske BL, Lai CL, Morales JM, Patel PR, Pol S, Silva MO, Balk EM, Gordon CE, Earley A, di M, Martin P (2018) Executive summary of the 2018 KDIGO hepatitis C in CKD guideline: welcoming advances in evaluation and management. Kidney Int 94:663\u2013673. \nhttps:\/\/doi.org\/10.1016\/j.kint.2018.06.011","journal-title":"Kidney Int"},{"issue":"part 2","key":"4625_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","volume":"95","author":"BH Rovin","year":"2019","unstructured":"Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J, Adler SG, Alpers CE, Ayoub I, Bagga A, Barbour SJ, Barratt J, Chan DTM, Chang A, Choo JCJ, Cook HT, Coppo R, Fervenza FC, Fogo AB, Fox JG, Glassock RJ, Harris D, Hodson EM, Hogan JJ, Hoxha E, Iseki K, Jennette JC, Jha V, Johnson DW, Kaname S, Katafuchi R, Kitching AR, Lafayette RA, Li PKT, Liew A, Lv J, Malvar A, Maruyama S, Mej\u00eda-Vilet JM, Mok CC, Nachman PH, Nester CM, Noiri E, O\u2019Shaughnessy MM, \u00d6zen S, Parikh SM, Park HC, Peh CA, Pendergraft WF, Pickering MC, Pillebout E, Radhakrishnan J, Rathi M, Ronco P, Smoyer WE, Tang SCW, Tesa\u0159 V, Thurman JM, Trimarchi H, Vivarelli M, Walters GD, Wang AYM, Wenderfer SE, Wetzels JFM (2019) Management and treatment of glomerular diseases (part 2): conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 95(part 2):281\u2013295. \nhttps:\/\/doi.org\/10.1016\/j.kint.2018.11.008","journal-title":"Kidney Int"},{"issue":"9","key":"4625_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/ki.2011.249","volume":"80","author":"S Guo","year":"2011","unstructured":"Guo S, Wietecha TA, Hudkins KL, Kida Y, Spencer MW, Pichaiwong W, Kojima I, Duffield JS, Alpers CE (2011) Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis. Kidney Int 80(9):946\u2013958. \nhttps:\/\/doi.org\/10.1038\/ki.2011.249","journal-title":"Kidney Int"},{"issue":"3","key":"4625_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.clim.2010.02.002","volume":"135","author":"M Ito","year":"2010","unstructured":"Ito M, Murakami K, Suzuki T, Mochida K, Suzuki M, Ikebuchi K, Yamaguchi K, Mizuochi T (2010) Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients. Clin Immunol 135(3):459\u2013465. \nhttps:\/\/doi.org\/10.1016\/j.clim.2010.02.002","journal-title":"Clin Immunol"},{"issue":"5","key":"4625_CR9","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/ki.1993.161","volume":"43","author":"D Roccatello","year":"1993","unstructured":"Roccatello D, Isidoro C, Mazzucco G, Mesiti A, Quattrocchio G, Amore A, Molino A, Coppo R, Sena LM, Piccoli G (1993) Role of monocytes in cryoglobulinemia-associated nephritis. Kidney Int 43(5):1150\u20131155. \nhttps:\/\/doi.org\/10.1038\/ki.1993.161","journal-title":"Kidney Int"},{"issue":"1","key":"4625_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.1997.475-ce1383.x","volume":"110","author":"D Roccatello","year":"1997","unstructured":"Roccatello D, Morsica G, Picciotto G et al (1997) Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection. Clin Exp Immunol 110(1):9\u201314. \nhttps:\/\/doi.org\/10.1111\/j.1365-2249.1997.475-ce1383.x","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"4625_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.gastro.2018.04.024","volume":"155","author":"M Bonacci","year":"2018","unstructured":"Bonacci M, Lens S, Mari\u00f1o Z, Londo\u00f1o MC, Rodriguez-Tajes S, S\u00e1nchez-Tapias JM, Ramos-Casals M, Hern\u00e1ndez-Rodr\u00edguez J, Forns X (2018) Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure. Gastroenterology. 155(2):311\u2013315.e6. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2018.04.024","journal-title":"Gastroenterology."},{"issue":"1","key":"4625_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311. \nhttps:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"4625_CR13","doi-asserted-by":"publisher","unstructured":"Pawlotsky J, Negro F, Aghemo A et al (2018) EASL recommendations on treatment of hepatitis C 2018. J Hepatol. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2018.03.026","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"4625_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1056\/NEJMra1208642","volume":"369","author":"F Dammacco","year":"2013","unstructured":"Dammacco F, Sansonno D (2013) Therapy for hepatitis C virus\u2013related cryoglobulinemic vasculitis. N Engl J Med 369:1035\u20131045. \nhttps:\/\/doi.org\/10.1056\/NEJMra1208642","journal-title":"N Engl J Med"},{"issue":"2","key":"4625_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT (2016) Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 63(2):408\u2013417. \nhttps:\/\/doi.org\/10.1002\/hep.28297","journal-title":"Hepatology."},{"issue":"3","key":"4625_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1182\/blood-2009-10-245878.The","volume":"116","author":"F Dammacco","year":"2010","unstructured":"Dammacco F, Tucci FA, Lauletta G, Gatti P, de Re V, Conteduca V, Sansonno S, Russi S, Mariggio MA, Chironna M, Sansonno D (2010) Pegylated interferon, ribavirin, and rituximab combined therapy of hepatitis C virus \u2013 related mixed cryoglobulinemia : a long-term study. Blood. 116(3):343\u2013353. \nhttps:\/\/doi.org\/10.1182\/blood-2009-10-245878.The","journal-title":"Blood."},{"key":"4625_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jcv.2015.09.003","volume":"72","author":"M Makara","year":"2015","unstructured":"Makara M, Sulyok M, Csacsovszki O, Sulyok Z, V\u00e1lyi-nagy I (2015) Successful treatment of HCV-associated cryoglobulinemia with ombitasvir \/ paritaprevir \/ ritonavir , dasabuvir and ribavirin : a case report. J Clin Virol 72:66\u201368. \nhttps:\/\/doi.org\/10.1016\/j.jcv.2015.09.003","journal-title":"J Clin Virol"},{"key":"4625_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/annrheumdis-2015-208339","volume":"75","author":"D Saadoun","year":"2015","unstructured":"Saadoun D, Thibault V, Nafa S et al (2015) Sofosbuvir plus ribavirin for hepatitis C virus- associated cryoglobulinaemia vasculitis : VASCUVALDIC study. Ann Rheum Dis 75:1\u20136. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2015-208339","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4625_CR19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00325481.2015.1021660","volume":"127","author":"SL Cornella","year":"2015","unstructured":"Cornella SL, Stine JG, Kelly V, Caldwell SH, Shah NL (2015) Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: a case series. Postgrad Med 127(4):413\u2013417. \nhttps:\/\/doi.org\/10.1080\/00325481.2015.1021660","journal-title":"Postgrad Med"},{"issue":"1","key":"4625_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13730-016-0244-z","volume":"6","author":"F Obata","year":"2017","unstructured":"Obata F, Murakami T, Miyagi J, Ueda S, Inagaki T, Minato M, Ono H, Nishimura K, Shibata E, Tamaki M, Yoshimoto S, Kishi F, Kishi S, Matsuura M, Nagai K, Abe H, Doi T (2017) A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant. CEN Case Reports 6(1):55\u201360. \nhttps:\/\/doi.org\/10.1007\/s13730-016-0244-z","journal-title":"CEN Case Reports"},{"issue":"5","key":"4625_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.28753","volume":"64","author":"L Gragnani","year":"2016","unstructured":"Gragnani L, Visentini M, Fognani E, Urraro T, de Santis A, Petraccia L, Perez M, Ceccotti G, Colantuono S, Mitrevski M, Stasi C, del Padre M, Monti M, Gianni E, Pulsoni A, Fiorilli M, Casato M, Zignego AL (2016) Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 64(5):1473\u20131482. \nhttps:\/\/doi.org\/10.1002\/hep.28753","journal-title":"Hepatology."},{"key":"4625_CR22","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/ijlh.12426","volume":"37","author":"P Cacoub","year":"2017","unstructured":"Cacoub P, Vautier M, Desbois AC, Lafuma A, Saadoun D (2017) Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: from interferon-based to direct-acting antivirals era. Liver Int 37:1805\u20131813. \nhttps:\/\/doi.org\/10.1111\/ijlh.12426","journal-title":"Liver Int"},{"issue":"9","key":"4625_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/hepr.12629","volume":"46","author":"M Tsuge","year":"2016","unstructured":"Tsuge M, Hiramatsu A, Shinohara F, Nakano N, Nakamura Y, Hatooka M, Morio K, Morio R, Kan H, Fujino H, Uchida T, Kobayashi T, Fukuhara T, Masaki K, Nakahara T, Ono A, Nagaoki Y, Miki D, Kawaoka T, Hiraga N, Imamura M, Kawakami Y, Aikata H, Ochi H, Nelson Hayes C, Chayama K (2016) Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: a case report. Hepatol Res 46(9):944\u2013948. \nhttps:\/\/doi.org\/10.1111\/hepr.12629","journal-title":"Hepatol Res"},{"issue":"11","key":"4625_CR24","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/rheumatology\/kew268","volume":"55","author":"S Sollima","year":"2016","unstructured":"Sollima S, Milazzo L, Peri AM, Torre A, Antinori S, Galli M (2016) Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy. Rheumatol (United Kingdom) 55(11):2084\u20132085. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kew268","journal-title":"Rheumatol (United Kingdom)"},{"issue":"2","key":"4625_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/j.ajkd.2017.01.041","volume":"70","author":"R Chowdhury","year":"2017","unstructured":"Chowdhury R, Tsen A (2017) Recurrent mixed cryoglobulinemia despite sustained virologic response to treatment: a case report. Am J Kidney Dis 70(2):301\u2013304. \nhttps:\/\/doi.org\/10.1053\/j.ajkd.2017.01.041","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"4625_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cgh.2016.09.158","volume":"15","author":"M Bonacci","year":"2017","unstructured":"Bonacci M, Lens S, Londo\u00f1o MC, Mari\u00f1o Z, Cid MC, Ramos-Casals M, S\u00e1nchez-Tapias JM, Forns X, Hern\u00e1ndez-Rodr\u00edguez J (2017) Virologic, clinical, and immune response outcomes of patients with hepatitis C virus\u2013associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol 15(4):575\u2013583.e1. \nhttps:\/\/doi.org\/10.1016\/j.cgh.2016.09.158","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4625_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1280-6","volume":"2017","author":"G Lauletta","year":"2017","unstructured":"Lauletta G, Russi S, Pavone F, Vacca A, Dammacco F (2017) Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia : a single-centre experience. Arthritis Res Ther 2017:1\u201310. \nhttps:\/\/doi.org\/10.1186\/s13075-017-1280-6","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4625_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12882-017-0534-5","volume":"18","author":"M Shimada","year":"2017","unstructured":"Shimada M, Nakamura N, Endo T, Yamabe H, Nakamura M, Murakami R, Narita I, Tomita H (2017) Daclatasvir\/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report. BMC Nephrol 18(1):18\u201321. \nhttps:\/\/doi.org\/10.1186\/s12882-017-0534-5","journal-title":"BMC Nephrol"},{"key":"4625_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.gastro.2017.03.006","volume":"153","author":"D Saadoun","year":"2017","unstructured":"Saadoun D, Pol S, Ferfar Y, Alric L, Hezode C, Si Ahmed SN, de Saint Martin L, Comarmond C, Bouyer AS, Musset L, Poynard T, Resche Rigon M, Cacoub P (2017) Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterology. 153:49\u201352.e5. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2017.03.006","journal-title":"Gastroenterology."},{"key":"4625_CR30","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/1744-1633.12020","volume":"65","author":"M Artemova","year":"2017","unstructured":"Artemova M, Abdurakhmanov D, Ignatova T, Mukhin N (2017) Persistent HCV-associated cryoglobulinemic vasculitis following virus eradication after direct-acting antivirals therapy. Hepatology. 65:1769\u20131770. \nhttps:\/\/doi.org\/10.1111\/1744-1633.12020","journal-title":"Hepatology."},{"issue":"8","key":"4625_CR31","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ajg.2017.49","volume":"112","author":"JS Emery","year":"2017","unstructured":"Emery JS, Kuczynski M, La D et al (2017) Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol 112(8):1298\u20131308. \nhttps:\/\/doi.org\/10.1038\/ajg.2017.49","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"4625_CR32","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1053\/j.gastro.2017.02.037","volume":"152","author":"C Comarmond","year":"2017","unstructured":"Comarmond C, Garrido M, Pol S, Desbois AC, Costopoulos M, le Garff-Tavernier M, Si Ahmed SN, Alric L, Fontaine H, Bellier B, Maciejewski A, Rosenzwajg M, Klatzmann D, Musset L, Poynard T, Cacoub P, Saadoun D (2017) Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus\u2013induced cryoglobulinemia vasculitis. Gastroenterology. 152(8):2052\u20132062.e2. \nhttps:\/\/doi.org\/10.1053\/j.gastro.2017.02.037","journal-title":"Gastroenterology."},{"issue":"05","key":"4625_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5414\/CN109019","volume":"87","author":"M Ghosn","year":"2017","unstructured":"Ghosn M, Palmer M, Najem C, Haddad D, Merkel P, Hogan J (2017) New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy. Clin Nephrol 87(05):261\u2013266. \nhttps:\/\/doi.org\/10.5414\/CN109019","journal-title":"Clin Nephrol"},{"issue":"4","key":"4625_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ekir.2018.03.016","volume":"3","author":"D Santoriello","year":"2018","unstructured":"Santoriello D, Pullela NK, Uday KA, Dhupar S, Radhakrishnan J, D\u2019Agati VD, Markowitz GS (2018) Persistent hepatitis C virus\u2212associated cryoglobulinemic glomerulonephritis in patients successfully treated with direct-acting antiviral therapy. Kidney Int Reports 3(4):985\u2013990. \nhttps:\/\/doi.org\/10.1016\/j.ekir.2018.03.016","journal-title":"Kidney Int Reports"},{"key":"4625_CR35","doi-asserted-by":"crossref","unstructured":"Comstock E, Kim C, Murphy A et al (2017) Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis. PLoS One:1\u201314","DOI":"10.1371\/journal.pone.0188314"},{"key":"4625_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","volume":"15","author":"K Oleinika","year":"2018","unstructured":"Oleinika K, Mauri C, Salama AD (2018) Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol 15:11\u201326. \nhttps:\/\/doi.org\/10.1038\/s41581-018-0074-7","journal-title":"Nat Rev Nephrol"},{"key":"4625_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/rheumatology\/kel174","volume":"46","author":"M Fabris","year":"2007","unstructured":"Fabris M, Quartuccio L, Sacco S, de Marchi G, Pozzato G, Mazzaro C, Ferraccioli G, Migone TS, de Vita S (2007;(May 2006) B-lymphocyte stimulator ( BLyS ) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology. 46:37\u201343. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kel174","journal-title":"Rheumatology."},{"issue":"4","key":"4625_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.kint.2018.05.021","volume":"94","author":"M De Rosa","year":"2018","unstructured":"De Rosa M, Azzato F, Toblli JE et al (2018) A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy. Kidney Int 94(4):788\u2013794. \nhttps:\/\/doi.org\/10.1016\/j.kint.2018.05.021","journal-title":"Kidney Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04625-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04625-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:21:16Z","timestamp":1591312876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04625-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4625"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04625-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted after institutional approval (The Ethics Committee of Fundeni Clinical Institute, Registration Number, 23249) aligned with the provisions of the Declaration of Helsinki and written consent to participate in the study was provided by all participating patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}